GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation<i>in vitro</i>

Abstract

GnRH agonist treatment with chemotherapy does not prevent or ameliorate ovarian damage and follicle loss in vitro. These data can be useful when consulting a young patient who may wish to receive GnRH treatment with chemotherapy to protect her ovaries from chemotherapy-induced damage.